{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:43:58Z","timestamp":1775141038569,"version":"3.50.1"},"reference-count":23,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,25]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>We describe a case of a 48-year-old woman who presented with acute respiratory failure due to diffuse alveolar haemorrhage and acute renal failure due to pauci-immune glomerulonephritis consistent with a new diagnosis of microscopic polyangiitis (MPA). The patient had a recent SARS-CoV-2 infection 6\u2009weeks before MPA diagnosis and had stopped immunosuppression for her rheumatoid arthritis (RA) at that time. The patient was treated with pulse intravenous steroids, plasma exchange therapy and rituximab, which induced remission of her illness. This case highlights a timely dilemma of holding immunosuppression in a RA patient with low disease activity on combination therapy with SARS-CoV-2 infection, and the potential risk of developing an additional autoimmune disease, such as vasculitis, given their existing autoimmunity due to RA.<\/jats:p>","DOI":"10.1136\/bcr-2020-241125","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T12:01:01Z","timestamp":1618228861000},"page":"e241125","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Does withdrawal of immunosuppression in rheumatoid arthritis after SARS-CoV-2 infection increase the risk of vasculitis?"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9968-6625","authenticated-orcid":false,"given":"Sukhraj","family":"Singh","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, UF Health Jacksonville, Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zareen","family":"Vaghaiwalla","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, UF Health Jacksonville, Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myint","family":"Thway","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, UF Health Jacksonville, Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurjit Singh","family":"Kaeley","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, UF Health Jacksonville, Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"2025082723105871000_14.4.e241125.1","unstructured":"The COVID-19 global rheumatology alliance global registry. Available: https:\/\/rheum-covid.org\/updates\/combined-data.html"},{"key":"2025082723105871000_14.4.e241125.2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/acr.23426","article-title":"Impact of sustained remission on the risk of serious infection in patients with rheumatoid arthritis","volume":"70","author":"Accortt","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025082723105871000_14.4.e241125.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128637"},{"key":"2025082723105871000_14.4.e241125.4","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s10067-020-05160-x","article-title":"COVID-19 with rheumatic diseases: a report of 5 cases","volume":"39","author":"Cheng","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025082723105871000_14.4.e241125.5","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s10067-020-05358-z","article-title":"Managing rheumatoid arthritis during COVID-19","volume":"39","author":"Roongta","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025082723105871000_14.4.e241125.6","unstructured":"Mikuls TR , Johnson SR , Fraenkel L . American College of rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3. Arthritis & Rheumatology."},{"key":"2025082723105871000_14.4.e241125.7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/art.41388","article-title":"Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?","volume":"72","author":"Favalli","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025082723105871000_14.4.e241125.8","unstructured":"Almashat SA . \"Vasculitis in COVID-19: A Literature Review\". J Vasc 2020."},{"key":"2025082723105871000_14.4.e241125.9","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2665-9913(20)30095-3","article-title":"Rheumatic disease and COVID-19: initial data from the COVID-19 global rheumatology alliance provider registries","volume":"2","author":"Gianfrancesco","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2025082723105871000_14.4.e241125.10","doi-asserted-by":"crossref","DOI":"10.1186\/s40064-015-0835-8","article-title":"Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome","volume":"4","author":"Draibe","year":"2015","journal-title":"Springerplus"},{"key":"2025082723105871000_14.4.e241125.11","first-page":"54","article-title":"Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis","volume":"54","author":"Qarni","year":"2000","journal-title":"Clin Nephrol"},{"key":"2025082723105871000_14.4.e241125.12","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220509","article-title":"Rheumatoid arthritis causing diffuse alveolar haemorrhage: a novel therapeutic approach","volume":"2017","author":"Osman","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2025082723105871000_14.4.e241125.13","doi-asserted-by":"crossref","DOI":"10.4046\/trd.2013.74.4.151","article-title":"Diffuse alveolar hemorrhage","volume":"74","author":"Park","year":"2013","journal-title":"Tuberc Respir Dis"},{"key":"2025082723105871000_14.4.e241125.14","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/rheumatology\/keaa581","article-title":"COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion","volume":"59","author":"Vacchi","year":"2020","journal-title":"Rheumatology"},{"key":"2025082723105871000_14.4.e241125.15","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3176"},{"key":"2025082723105871000_14.4.e241125.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.04.007"},{"key":"2025082723105871000_14.4.e241125.17","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"The Lancet"},{"key":"2025082723105871000_14.4.e241125.18","doi-asserted-by":"crossref","unstructured":"Brito CA , Paiva JG , Pimentel FN . Rosinete Santos Guimar\u00e3es, and Mariana Ribeiro Moreira. \u201cCOVID-19 in Patients with Rheumatological Diseases Treated with Anti-TNF.\u201d. Annals of the Rheumatic Diseases 2020.","DOI":"10.1136\/annrheumdis-2020-218171"},{"key":"2025082723105871000_14.4.e241125.19","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID) . A multicenter, adaptive, randomized blinded controlled trial of the safety and efficacy of investigational therapeutics for the treatment of COVID-19 in hospitalized adults (ACTT-2). ClinicalTrials.gov, 2020. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04401579 [Accessed 05 Nov 2020]."},{"key":"2025082723105871000_14.4.e241125.20","article-title":"Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic","author":"Fragoulis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025082723105871000_14.4.e241125.21","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/1756-185X.13960","article-title":"Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: a study in 15 Arab countries","volume":"23","author":"Ziad\u00e9","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2025082723105871000_14.4.e241125.22","unstructured":"England NHS . Clinical guide for the management of rheumatology patients during the coronavirus pandemic, 2020."},{"key":"2025082723105871000_14.4.e241125.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102523"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-241125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:11:14Z","timestamp":1756361474000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-241125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,12]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-241125"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-241125","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}